A citation-based method for searching scientific literature

Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
Times Cited: 81



Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
Times Cited: 744




List of shared articles



Times cited

TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients.
Jun Park, Sungjoo Lee, Kyunga Kim, Hyunju Park, Chang-Seok Ki, Young Lyun Oh, Jung Hee Shin, Jee Soo Kim, Sun Wook Kim, Jae Hoon Chung,[...]. Cancers (Basel) 2021
5


Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy.
Jierui Liu, Yanqing Liu, Yansong Lin, Jun Liang. Endocrinol Metab (Seoul) 2019
15

The Increased Risk of Thyroid Cancer-Specific Mortality With Tumor Size in Stage IVB Patients.
Junyi Zhang, Xiaoyun Cheng, Bin Su, Xingchun Wang, Lu Wang, Muthukumaran Jayachandran, Xiaoting Sun, Le Bu, Yueye Huang, Shen Qu. Front Oncol 2020
1

Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer.
Miguel A Zaballos, Adrián Acuña-Ruiz, Marta Morante, Piero Crespo, Pilar Santisteban. Endocr Relat Cancer 2019
8

The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis.
Ling Zhao, Lin Wang, Xiaomeng Jia, Xiaodong Hu, Ping Pang, Sitong Zhao, Yajing Wang, Jing Wang, Yingshi Zhang, Zhaohui Lyu. Front Oncol 2020
4

Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.
Jinwei Hu, Isabella J Yuan, Saied Mirshahidi, Alfred Simental, Steve C Lee, Xiangpeng Yuan. Int J Mol Sci 2021
3

Coding Molecular Determinants of Thyroid Cancer Development and Progression.
Veronica Valvo, Carmelo Nucera. Endocrinol Metab Clin North Am 2019
8

Diagnosis and Management of Anaplastic Thyroid Cancer.
Ashish V Chintakuntlawar, Robert L Foote, Jan L Kasperbauer, Keith C Bible. Endocrinol Metab Clin North Am 2019
27

Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.
Isabella Maria Dias Payão Ortiz, Mateus Camargo Barros-Filho, Mariana Bisarro Dos Reis, Caroline Moraes Beltrami, Fabio Albuquerque Marchi, Hellen Kuasne, Luísa Matos do Canto, Julia Bette Homem de Mello, Cecilie Abildgaard, Clóvis Antônio Lopes Pinto,[...]. Clin Epigenetics 2018
19

Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling.
Yina Liao, Yao Gao, An Chang, Zongjuan Li, Huayu Wang, Jing Cao, Wei Gu, Ranran Tang. J Cell Mol Med 2020
5